Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT05408923
Other study ID # 2083162
Secondary ID
Status Withdrawn
Phase Phase 4
First received
Last updated
Start date July 2022
Est. completion date July 2026

Study information

Verified date December 2022
Source University of Missouri-Columbia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To compare post-operative wound complications in patients randomized to normal saline versus Irrisept solution and any other adverse reactions from the solution.


Description:

Wound complications represent a significant risk factor in spinal surgery, particularly in complex multilevel procedures. Surgical site infections (SSI) are the most common health care-associated infection, accounting for 31% of all hospitalized patients with a health care-associated infection. The reported incidence of SSIs following spine surgery ranges from 0.2% to 18.8%. In one study, each episode of wound infection following spine procedure contributed to a mean increase in the cost of care by $4,067 compared to a non-complicated case. The bacteria can adhere to the implants and tissues to create biofilm made by polysaccharide matrix which makes it challenging to clear the infection. Different irrigation techniques and solutions have been utilized to help limit post-operative wound complications. No studies have compared Irrisept solution to normal saline to see if there is a difference in wound complications for posterior spine surgeries.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date July 2026
Est. primary completion date July 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Presenting to the University of Missouri hospital system - including the University of Missouri Hospital and Missouri Orthopaedic Institute - with a need for isolated open posterior spine procedures using a posterior open approach. - Failed conservative treatment - rest, anti-inflammatory medications, physical therapy - >18 years old and able to provide informed consent Exclusion Criteria: - Ongoing or suspected infection - Revisions of failed back surgeries - Documented allergy to CHG or CHG products - Pregnancy - qualitative beta human chorionic gonadotropin (hCG) testing will be performed prior to enrollment - Prisoners or wards of the state - Unable to consent to research study

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
saline 0.9%
Control group will get normal saline for irrigation throughout the case.
(0.05% chlorhexidine gluconate (CHG) in sterile water)
Intervention group will get Irrisept irrigation (0.05% CHG in sterile water) throughout the case.

Locations

Country Name City State
United States Missouri Orthopaedic Institute Columbia Missouri

Sponsors (1)

Lead Sponsor Collaborator
University of Missouri-Columbia

Country where clinical trial is conducted

United States, 

References & Publications (8)

Chahoud J, Kanafani Z, Kanj SS. Surgical site infections following spine surgery: eliminating the controversies in the diagnosis. Front Med (Lausanne). 2014 Mar 24;1:7. doi: 10.3389/fmed.2014.00007. eCollection 2014. — View Citation

De Luna V, Mancini F, De Maio F, Bernardi G, Ippolito E, Caterini R. Intraoperative Disinfection by Pulse Irrigation with Povidone-Iodine Solution in Spine Surgery. Adv Orthop. 2017;2017:7218918. doi: 10.1155/2017/7218918. Epub 2017 Oct 2. — View Citation

Magill SS, Hellinger W, Cohen J, Kay R, Bailey C, Boland B, Carey D, de Guzman J, Dominguez K, Edwards J, Goraczewski L, Horan T, Miller M, Phelps M, Saltford R, Seibert J, Smith B, Starling P, Viergutz B, Walsh K, Rathore M, Guzman N, Fridkin S. Prevalence of healthcare-associated infections in acute care hospitals in Jacksonville, Florida. Infect Control Hosp Epidemiol. 2012 Mar;33(3):283-91. doi: 10.1086/664048. Epub 2012 Jan 12. — View Citation

Onishi Y, Masuda K, Tozawa K, Karita T. Outcomes of an Intraoperative Povidone-Iodine Irrigation Protocol in Spinal Surgery for Surgical Site Infection Prevention. Clin Spine Surg. 2019 Dec;32(10):E449-E452. doi: 10.1097/BSD.0000000000000908. — View Citation

Rechtine GR, Bono PL, Cahill D, Bolesta MJ, Chrin AM. Postoperative wound infection after instrumentation of thoracic and lumbar fractures. J Orthop Trauma. 2001 Nov;15(8):566-9. doi: 10.1097/00005131-200111000-00006. — View Citation

Silber JS, Anderson DG, Vaccaro AR, Anderson PA, McCormick P; NASS. Management of postprocedural discitis. Spine J. 2002 Jul-Aug;2(4):279-87. doi: 10.1016/s1529-9430(02)00203-6. — View Citation

Watanabe M, Sakai D, Matsuyama D, Yamamoto Y, Sato M, Mochida J. Risk factors for surgical site infection following spine surgery: efficacy of intraoperative saline irrigation. J Neurosurg Spine. 2010 May;12(5):540-6. doi: 10.3171/2009.11.SPINE09308. — View Citation

Whitmore RG, Stephen J, Stein SC, Campbell PG, Yadla S, Harrop JS, Sharan AD, Maltenfort MG, Ratliff JK. Patient comorbidities and complications after spinal surgery: a societal-based cost analysis. Spine (Phila Pa 1976). 2012 May 20;37(12):1065-71. doi: 10.1097/BRS.0b013e31823da22d. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Center for Disease Control (CDC)-defined 90-day surgical site infection incidence Comparing post-operative surgical site infection incidence between groups for 90 days post-operative using chi-square test. 90 days after surgery
Secondary Wound healing Comparing post-operative wound healing incidence between groups for 90 days post-operative using t-Test 90 days after surgery
Secondary Wound complications Comparing post-operative wound complications incidence between groups for 90 days post-operative using chi-square test. 90 days after surgery
See also
  Status Clinical Trial Phase
Recruiting NCT04140344 - The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions N/A
Completed NCT04914728 - Mini-invasive Lumbar Arthrodesis in Ambulatory N/A
Recruiting NCT05527145 - Spinal Stenosis and Listhesis Treated With Percutaneous Interspinous Spacer: a Non-surgical Trial N/A
Completed NCT05630404 - Efficacy of Surgical Injection Lumbar Erector Spinae Plane Block N/A
Recruiting NCT05452694 - OpalGenix- Personalized Postoperative Pain Management Following Lumbar Spinal Fusion and Decompression Surgery in Adults
Recruiting NCT04823858 - 3Spine Lumbar Fusion Real World Evidence Study
Recruiting NCT06154005 - OsteoAdapt SP Advanced Bone Graft Feasibility Study - Transforaminal Interbody Lumbar Fusion Phase 1/Phase 2
Recruiting NCT04781517 - Development of a Patient-reported Outcome Instrument for Patients With Lumbar Degenerative Disease After Lumbar Fusion
Completed NCT03977961 - The Six-Minute Walking Test (6MWT) as a Measure of Functional Impairment in Lumbar Degenerate Disc Disease.
Completed NCT03176303 - Study Using the SpinalStim Device Following Lumbar Fusion Surgery
Recruiting NCT06462729 - LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF) Phase 1/Phase 2
Completed NCT01143324 - A Prospective, Multicenter Observational Study on MASTâ„¢ (Minimal Access Spinal Technologies) Fusion Procedures for the Treatment of the Degenerative Lumbar Spine
Active, not recruiting NCT05438719 - MOTUS Total Joint Replacement Investigational Device Exemption Study N/A
Not yet recruiting NCT05388383 - Cost-effectiveness Analysis of Robot-assisted Spinal Surgery
Completed NCT06316921 - Epidural PCA on Pain Relief After L-spine Surgery
Completed NCT03452449 - Physical Activity, Disability and Quality of Life Before and After Lumbar Spine Surgery
Terminated NCT03527966 - rhBMP-2 Versus Vivigen in Lumbar Fusion Procedures Phase 4
Terminated NCT01415908 - INFUSE®Bone Graft in Transforaminal Lumbar Interbody Fusion for Degenerative Disease of Lumbosacral Spine Phase 3
Completed NCT04062942 - The Six-Minute Walking Test (6WT) and Timed-Up-and-Go (TUG) Test as Measures of Objective Functional Impairment in Patients Undergoing Interlaminar or Transforaminal Epidural Steroid Injection for Lumbar Degenerative Disc Disease (DDD)
Completed NCT03088306 - Improving Pain and Reducing Opioid Use (IPaRO) in Lumbar Spine Surgery Patients Early Phase 1